ONCOLOGY RES INT LTD has a total of 37 patent applications. Its first patent ever was published in 2000. It filed its patents most often in United States, Canada and China. Its main competitors in its focus markets pharmaceuticals and organic fine chemistry are EFFIK, PANAGIN PHARMACEUTICALS INC and BAKER CUMMINS PHARMA.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 6 | |
#2 | Canada | 4 | |
#3 | China | 4 | |
#4 | WIPO (World Intellectual Property Organization) | 4 | |
#5 | Australia | 3 | |
#6 | EAPO (Eurasian Patent Organization) | 3 | |
#7 | EPO (European Patent Office) | 3 | |
#8 | Mexico | 3 | |
#9 | Taiwan | 3 | |
#10 | Hong Kong | 2 | |
#11 | Brazil | 1 | |
#12 | India | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Steroids | |
#4 | Organic chemistry methods | |
#5 | Sugars |
# | Name | Total Patents |
---|---|---|
#1 | Story Michael John | 17 |
#2 | Wayte Kenneth Michael | 16 |
#3 | Walker David Millar | 15 |
#4 | Marshall Philip Andrew | 14 |
#5 | Mason Jennifer Mary | 6 |
#6 | Muscroft-Taylor Andrew Clive | 5 |
#7 | John Story Michael | 2 |
#8 | Michael Wayte Kenneth | 1 |
#9 | Michael Wayne Kenneth | 1 |
#10 | Marshall Philip | 1 |
Publication | Filing date | Title |
---|---|---|
CA2659542A1 | Methods and compositions for inhibiting angiogenesis | |
EP2049121A1 | Compositions for promoting activity of anti-cancer therapies | |
AUPS167102A0 | Pharmaceutical composition | |
AUPR430501A0 | Pharmaceutical composition | |
AUPQ678400A0 | Pharmaceutical composition |